While non-small cell lung cancer (NSCLC) exhibited slightly decreased median ACE2 expression (0.95 TPM) compared to normal tissue, a subset of NSCLC tumors (N = 64, 0.85%) demonstrated severely increased expression (> 50 TPM). Here, ACE2 is linked to non-small cell lung carcinoma.